Behcet's Syndrome: European Treatment Guidelines Updated (CME/CE)
(MedPage Today) -- Controversies include use of biologics for ocular disease, anticoagulation for DVT (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - April 11, 2018 Category: Rheumatology Source Type: news

What Causes White Nails?
Discussion The nail matrix covers the area of the nail plate, and extends proximally in a crescent moon shape with the edges of the crescent extending proximally and inferiorly toward the underlying bone. The nail matrix is a multilayered epithelium that physiologically produces keratinization and gives rise to the nail plate. The distal matrix forms the lower 2/3s of the nail plate and the proximal matrix forms the upper 1/3 of the nail plate. the thickness of the nail plate is proportion to the matrix’s thickness. The nail plate’s free edge contour follows the shape of the nail’s lunula. Melanocytes occ...
Source: PediatricEducation.org - November 6, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Behcet's Syndrome
Title: Behcet's SyndromeCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/19/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 19, 2016 Category: Rheumatology Source Type: news

Medical News Today: What is Behcet's Disease? Symptoms and Prognosis
Learn about Behcet's disease, a rare condition that causes inflammation to blood vessels. This disease can cause a variety of symptoms that may not appear connected. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 19, 2016 Category: Consumer Health News Tags: Vascular Source Type: news

'Behcet's disease can now be treated with homeopathy'
Behcet's disease, one of the rarest immunological disorders where a patient suffers serious ulcerations in mouth and genitals, can now be treated with homeopathy. (Source: The Economic Times)
Source: The Economic Times - September 14, 2015 Category: Consumer Health News Source Type: news

Already with $1 billion in losses, Xoma plummets with late-stage drug failure
Xoma Corp. continued tumbling Friday after its headline drug failed a late-stage clinical trial in patients with a blinding eye disease. Berkeley-based Xoma's (NASDAQ: XOMA) stock closed at 94 cents per share Friday, down nearly 9 cents from the previous close. From a Tuesday close of $4.39, the stock had fallen as low as 85 cents on Wednesday's news of the drug's failure in a study of patients with Behcet's uveitis, a potentially blinding chronic inflammation of blood vessels in the eye. The drug,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 24, 2015 Category: Biotechnology Authors: Ron Leuty Source Type: news

Already with $1 billion in losses, Xoma plummets with late-stage drug failure
Xoma Corp. continued tumbling Friday after its headline drug failed a late-stage clinical trial in patients with a blinding eye disease. Berkeley-based Xoma's (NASDAQ: XOMA) stock closed at 94 cents per share Friday, down nearly 9 cents from the previous close. From a Tuesday close of $4.39, the stock had fallen as low as 85 cents on Wednesday's news of the drug's failure in a study of patients with Behcet's uveitis, a potentially blinding chronic inflammation of blood vessels in the eye. The drug,… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - July 24, 2015 Category: Hospital Management Authors: Ron Leuty Source Type: news

Anti-IL-1 Drugs Safe, Effective in Behcet's Disease (CME/CE)
(MedPage Today) -- The rare inflammatory condition responds to anti-interleukin agents, researchers concluded. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - July 24, 2015 Category: Rheumatology Source Type: news

An Update on Intestinal Behcet's DiseaseAn Update on Intestinal Behcet's Disease
What recent developments have been made in the diagnosis, treatment, and prognosis of intestinal Behcet's disease? Current Opinion in Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2015 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

XOMA begins US clinical trial of gevokizumab to treat Behcet's disease uveitis
US-based therapeutic antibodies manufacturer XOMA has started patient enrolment in its EYEGUARD-US supplemental clinical trial designed to evaluate the efficacy and safety of gevokizumab in treating Behçet's disease uveitis. (Source: Drug Development Technology)
Source: Drug Development Technology - September 30, 2014 Category: Pharmaceuticals Source Type: news

TNF Inhibitor Therapy Effective for Behcet's Disease UveitisTNF Inhibitor Therapy Effective for Behcet's Disease Uveitis
When uveitis due to Behcet's disease fails to respond to conventional therapy, anti-TNF-alpha therapy may help, according to a Spanish study. Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - July 21, 2014 Category: Opthalmology Tags: Rheumatology News Source Type: news

Outcomes in Neuro-Behçet'sOutcomes in Neuro-Behçet's
Neuro-Behcet's is a severe condition, and this characteristic makes it worse. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2014 Category: Consumer Health News Tags: Rheumatology Viewpoint Source Type: news

Apremilast Clears Behcet's Ulcers
SAN DIEGO (MedPage Today) -- An investigational small molecule known as apremilast was successful in clearing the oral ulcers characteristic of Behcet's syndrome, a researcher reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 28, 2013 Category: Dermatology Source Type: news

Apremilast Potential Treatment for Behcet'sApremilast Potential Treatment for Behcet's
Few options are available for this rare inflammatory disease, and the first-in-class oral targeted phosphodiesterase 4 inhibitor quickly relieves the painful oral and genital ulcers of Behcet's. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 28, 2013 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Approaches to Immunosuppression in Behcet's DiseaseApproaches to Immunosuppression in Behcet's Disease
Gain new insights into Becet's Disease immunopathology and a new area of targeted therapy. Immunotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2013 Category: Consumer Health News Tags: Allergy & Clinical Immunology Journal Article Source Type: news